Immunotherapy with either antithymocyteglobulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.
AIM To explore the effect of low-dose and short-term antithymocyteglobulin(ATG) in treatment of early steroid-resistant rejection after renal transplantation.
目的探讨低剂量、短疗程的抗胸腺细胞球蛋白(ATG)治疗肾移植后早期激素耐受性排斥反应的疗效。
3
Objective To analyze effects of antithymocyteglobulin(ATG) in preventing the occurrence of graft-versus-host disease(GVHD) in allogeneic stem cells transplantation.